Paper36720642
Testing for Alzheimer Disease Biomarkers and Disclosing Results Across the Disease Continuum.
Largent EA and 5 others. Neurology, 2023. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. Testing for Alzheimer Disease Biomarkers and Disclosing Results Across the Disease Continuum. Papers, record 36720642. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36720642
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Cognitive Dysfunction | Major topic |
| Humans | |
| Amyloid beta-Peptides | |
| Biomarkers | |
| Educational Status | |
| tau Proteins |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K01 AG064123 | NIA NIH HHS | United States | K01AG064123 | PubMed and NIH | NIH RePORTER |
| P30 AG072979 | NIA NIH HHS | United States | P30AG072979 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 36792374 | Scientific, Ethical, and Practical Considerations for the Testing and Disclosure of Alzheimer Disease Biomarkers. | https://conductscience.org/library/papers/36792374 |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29197423 | Amnestic MCI patients' experiences after disclosure of their amyloid PET result in a research context. | Alzheimers Res Ther | 2017 | https://conductscience.org/library/papers/29197423 | PubMed |
| 2 | 30681701 | The Rise of Pseudomedicine for Dementia and Brain Health. | JAMA | 2019 | https://conductscience.org/library/papers/30681701 | PubMed |
| 3 | 26167204 | Amyloid imaging, risk disclosure and Alzheimer's disease: ethical and practical issues. | Neurodegener Dis Manag | 2013 | https://conductscience.org/library/papers/26167204 | PubMed |
| 4 | 25984909 | Predictive testing for Alzheimer's disease: suicidal ideation in healthy participants. | Alzheimer Dis Assoc Disord | 2015 | https://conductscience.org/library/papers/25984909 | PubMed |
| 5 | 23098912 | Current knowledge and future directions about the disclosure of dementia: a systematic review of the first decade of the 21st century. | Alzheimers Dement | 2013 | https://conductscience.org/library/papers/23098912 | PubMed |
| 6 | 29059270 | Comprehension of an Elevated Amyloid Positron Emission Tomography Biomarker Result by Cognitively Normal Older Adults. | JAMA Neurol | 2018 | https://conductscience.org/library/papers/29059270 | PubMed |
| 7 | 10964998 | SPIKES-A six-step protocol for delivering bad news: application to the patient with cancer. | Oncologist | 2000 | https://conductscience.org/library/papers/10964998 | PubMed |
| 8 | 32734458 | Clinical impact of 18F-FDG-PET among memory clinic patients with uncertain diagnosis. | Eur J Nucl Med Mol Imaging | 2021 | https://conductscience.org/library/papers/32734458 | PubMed |
| 9 | 20094021 | Seeking assent and respecting dissent in dementia research. | Am J Geriatr Psychiatry | 2010 | https://conductscience.org/library/papers/20094021 | PubMed |
| 10 | 34040780 | 'That would be dreadful': The ethical, legal, and social challenges of sharing your Alzheimer's disease biomarker and genetic testing results with others. | J Law Biosci | 2021 | https://conductscience.org/library/papers/34040780 | PubMed |
| 11 | 30261910 | Study partners: essential collaborators in discovering treatments for Alzheimer's disease. | Alzheimers Res Ther | 2018 | https://conductscience.org/library/papers/30261910 | PubMed |
| 12 | 30938796 | Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia. | JAMA | 2019 | https://conductscience.org/library/papers/30938796 | PubMed |
| 13 | 29653606 | NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. | Alzheimers Dement | 2018 | https://conductscience.org/library/papers/29653606 | PubMed |
| 14 | 33393982 | The Future Is P-Tau-Anticipating Direct-to-Consumer Alzheimer Disease Blood Tests. | JAMA Neurol | 2021 | https://conductscience.org/library/papers/33393982 | PubMed |
| 15 | 30147000 | The Proactive Patient: Long-Term Care Insurance Discrimination Risks of Alzheimer's Disease Biomarkers. | J Law Med Ethics | 2018 | https://conductscience.org/library/papers/30147000 | PubMed |
| 16 | 32777010 | Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment. | JAMA Neurol | 2020 | https://conductscience.org/library/papers/32777010 | PubMed |
| 17 | 27060950 | Development of a Standardized Approach to Disclosing Amyloid Imaging Research Results in Mild Cognitive Impairment. | J Alzheimers Dis | 2016 | https://conductscience.org/library/papers/27060950 | PubMed |
| 18 | 25022536 | The influence of cerebrospinal fluid (CSF) biomarkers on clinical dementia evaluations. | Alzheimers Dement | 2015 | https://conductscience.org/library/papers/25022536 | PubMed |
| 19 | 22437338 | Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010. | J Neuropathol Exp Neurol | 2012 | https://conductscience.org/library/papers/22437338 | PubMed |
| 20 | 10974954 | Truth-telling and the diagnosis of dementia. | Br J Psychiatry | 2000 | https://conductscience.org/library/papers/10974954 | PubMed |
Cited by46
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42832237 | Earlier Disclosure of Blood-Based Biomarkers, Diagnostic Certainty, and Clinical Management: A Randomized Clinical Trial. | JAMA Neurol | 2026 | https://conductscience.org/library/papers/42832237 | PubMed |
| 42507235 | Worry and Anxiety in the Era of Early Diagnosis and Disease Modifying Treatment for Alzheimer's Disease. | Curr Psychiatry Rep | 2026 | https://conductscience.org/library/papers/42507235 | PubMed |
| 42426363 | Defining and Measuring Cognitive Decline and Clinical Relevance. | Neurol Ther | 2026 | https://conductscience.org/library/papers/42426363 | PubMed |
| 42348506 | Just Semantics? How Diagnostic Criteria Influence Physician-Patient Narratives in Alzheimer's Disease. | Neurodegener Dis | 2026 | https://conductscience.org/library/papers/42348506 | PubMed |
| 42254757 | Study of the utility and impact of a plasma p-tau181 Alzheimer's biomarker (SUITABLE). | Alzheimers Dement (N Y) | 2026 | https://conductscience.org/library/papers/42254757 | PubMed |
| 41950013 | Expert consensus on communicating tau PET results to persons living with MCI or dementia: Findings from a modified Delphi study. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/41950013 | PubMed |
| 41929956 | Qualitative insights into participant and care partner perspectives on research-based Alzheimer's disease biomarker testing and disclosure. | J Alzheimers Dis Rep | 2026 | https://conductscience.org/library/papers/41929956 | PubMed |
| 41639575 | Biofluid biomarkers in Alzheimer's disease and other neurodegenerative dementias. | Nature | 2026 | https://conductscience.org/library/papers/41639575 | PubMed |
| 41623897 | Considerations for disclosing Alzheimer's disease risk and biomarker results in a Pueblo community in Southwest United States. | Alzheimers Dement (Amst) | 2026 | https://conductscience.org/library/papers/41623897 | PubMed |
| 41550025 | Genetic and Pathological Testing Attitudes for Parkinson's Disease in At-Risk Relatives. | Mov Disord Clin Pract | 2026 | https://conductscience.org/library/papers/41550025 | PubMed |
| 41500647 | What is the psychological and cognitive impact of returning Alzheimer disease dementia research results to healthy research participants? a delayed-start randomised clinical trial protocol for the WeSHARE study (Washington University study of having Alzheimer disease research results explained). | BMJ Open | 2026 | https://conductscience.org/library/papers/41500647 | PubMed |
| 41390659 | Disclosure of onset-predictive biomarker results to research participants at risk of genetic frontotemporal dementia: a European perspective. | Alzheimers Res Ther | 2025 | https://conductscience.org/library/papers/41390659 | PubMed |
| 41366831 | Clinical definition, biological characterization, and detection guidelines of subjective cognitive decline due to Alzheimer's disease and related dementia: A position paper from ISTAART SCD PIA. | Alzheimers Dement | 2025 | https://conductscience.org/library/papers/41366831 | PubMed |
| 41113830 | Fair allocation of telemedical counseling services in early detection of Alzheimer's disease: Empirically informed ethical considerations. | Alzheimers Dement (Amst) | 2025 | https://conductscience.org/library/papers/41113830 | PubMed |
| 40997223 | Recommended approaches to sharing individual research results in Alzheimer's disease research: A multidisciplinary expert Delphi consensus. | J Alzheimers Dis | 2025 | https://conductscience.org/library/papers/40997223 | PubMed |
| 40636063 | It is time to share Alzheimer biomarker results in dementia with Lewy bodies. | Alzheimers Dement (Amst) | 2025 | https://conductscience.org/library/papers/40636063 | PubMed |
| 40545555 | Return of research results across the Alzheimer's Disease Research Centers network. | Alzheimers Dement | 2025 | https://conductscience.org/library/papers/40545555 | PubMed |
| 40527327 | Moving from dementia risk disclosure to return of individual research results: a bioethics perspective. | Lancet Healthy Longev | 2025 | https://conductscience.org/library/papers/40527327 | PubMed |
| 40368121 | Toward a person-centered return of research results of dementia risk: A pluralistic, constructive expansion. | J Alzheimers Dis | 2025 | https://conductscience.org/library/papers/40368121 | PubMed |
| 40327345 | Research Participant Interest in Learning Results of Biomarker Tests for Alzheimer Disease. | JAMA Netw Open | 2025 | https://conductscience.org/library/papers/40327345 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36720642
GET https://conductscience.org/api/papers/v1/36720642/references?page=2